These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15146438)

  • 1. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
    Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
    Finnegan A; Mikecz K; Tao P; Glant TT
    J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritis.
    Van Vollenhoven RF; Soriano A; McCarthy PE; Schwartz RL; Garbrecht FC; Thorbecke GJ; Siskind GW
    J Immunol; 1988 Aug; 141(4):1168-73. PubMed ID: 3260920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
    Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
    Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT; Mikecz K
    Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice.
    Kai H; Shibuya K; Wang Y; Kameta H; Kameyama T; Tahara-Hanaoka S; Miyamoto A; Honda S; Matsumoto I; Koyama A; Sumida T; Shibuya A
    Immunology; 2006 Jun; 118(2):233-9. PubMed ID: 16771858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sinomenine on collagen-induced arthritis in mice.
    Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
    Autoimmunity; 2007 Nov; 40(7):532-9. PubMed ID: 17966044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice.
    Miyata M; Kobayashi H; Sasajima T; Sato Y; Kasukawa R
    Arthritis Rheum; 2000 Nov; 43(11):2578-82. PubMed ID: 11083283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
    Stasiuk LM; Abehsira-Amar O; Fournier C
    Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway.
    Yin H; Yu M; Cheng H; Zhang F; Gao Y; Lin J; Han B; Zhu L
    Neuro Endocrinol Lett; 2005 Dec; 26(6):739-44. PubMed ID: 16380673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
    Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
    Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
    Chiocchia G; Boissier MC; Manoury B; Fournier C
    Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
    Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
    Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.